12142017Headline:

New York City, New York

HomeNew YorkNew York City

Email Jeremy Thurman Jeremy Thurman on LinkedIn Jeremy Thurman on Twitter Jeremy Thurman on Facebook
Jeremy Thurman
Jeremy Thurman
Attorney • (877) 917-5250

Diabetes Drug Warning

Comments Off

A warning from U.S. regulators linking GlaxoSmithKline Plc’s diabetes drug Avandia to rare cases of swelling in the back of the eye is unlikely to have a major impact on sales, analysts said on Friday.

The Food and Drug Administration highlighted the problem in a notice late on Thursday after the drug maker said it had received “very rare” reports of the swelling, known as macular oedema, in patients taking Avandia.

The warning also applies to Avandamet, a combination product containing the same active ingredient, and Avandaryl, which will be available later in January.